Transforming growth factor alpha acts as a gliatrophin for mouse and human astrocytes

Oncogene

Volumn 25, Issue 29, 2006, Pages 4076-4085

  Sharif, A ^a,b   Prevot V ^a   Renault Mihara, F ^a,b   Allet, C ^a   Studler, J M ^a,b   Canton, B ^a,b   Chneiweiss, H ^a,b   Junier, M P ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Apoptosis; EGF; erbB1; Oncogenesis; Survival; Trophic factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLIATROPHIN; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIC FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR ALPHA; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EMBRYO; ARTICLE; ASTROCYTE; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FETUS; FETUS CELL; GLIOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MECHANOTRANSDUCTION; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; TUMOR GROWTH;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGING; ANIMALS; ASTROCYTES; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CEREBELLAR CORTEX; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLIOMA; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; ONCOGENE PROTEIN V-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TIME FACTORS; TRANSFORMING GROWTH FACTOR ALPHA;

MAMMALIA;

EID: 33745794886     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209443     Document Type: Article

References (69)

1. Bakhiet M, Tjernlund A, Mousa A, Gad A, Stromblad S, Kuziel WA et al. (2001). Nat Cell Biol 3: 150-157.
2. Barna BP, Mattera R, Jacobs BS, Drazba J, Estes ME, Prayson RA et al. (2001). Cell Immunol 208: 18-24.
3. Beck G, Fainzilber M. (2002). Neuron 33: 673-675.
4. Bergmann A, Tugentman M, Shilo BZ, Steller H. (2002). Dev Cell 2: 159-170.
5. Boillee S, Cadusseau J, Coulpier M, Grannec G, Junier MP. (2001). J Neurosci 21: 7079-7088.
6. Busse D, Doughty RS, Ramsey TT, Russell WE, Price JO, Flanagan WM et al. (2000). J Biol Chem 275: 6987-6995.
7. Chakravarti A, Chakladar A, Delaney MA, Latham DE, Loeffler JS. (2002). Cancer Res 62: 4307-4315.
8. Ciardiello F, Tortora G. (2003). Eur J Cancer 39: 1348-1354.
9. Di Iorio P, Ballerini P, Traversa U, Nicoletti F, D'Alimonte I, Kleywegt S et al. (2004). Glia 46: 356-368.
10. Duronio V, Scheid MP, Ettinger S. (1998). Cell Signal 10: 233-239.
11. Elenius K, Paul S, Allison G, Sun J, Klagsbrun M. (1997). EMBO J 16: 1268-1278.
12. Erlich S, Shohami E, Pinkas-Kramarski R. (2000). Mol Cell Neurosci 16: 597-608.
13. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS et al. (1998). J Biol Chem 273: 18623-18632.
14. Fernandez PA, Tang DG, Cheng L, Prochiantz A, Mudge AW, Raff MC. (2000). Neuron 28: 81-90.
15. Francis A, Raabe TD, Wen D, DeVries GH. (1999). J Neurosci Res 57: 487-494.
16. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. (2003). Oncogene 22: 8983-8998.
17. Gerecke KM, Wyss JM, Karavanova I, Buonanno A, Carroll SL. (2001). J Comp Neurol 433: 86-100.
18. Giffard RG, Swanson RA. (2005). Glia 50: 299-306.
19. Hanson Jr MG, Shen S, Wiemelt AP, McMorris FA, Barres BA. (1998). J Neurosci 18: 7361-7371.
20. Hertz L, Zielke HR. (2004). Trends Neurosci 27: 735-743.
21. Hidalgo A, Kinrade EF, Georgiou M. (2001). Dev Cell 1: 679-690.
22. Junier MP. (2000). Prog Neurobiol 62: 443-473.
23. Justicia C, Planas AM. (1999). J Cereb Blood Flow Metab 19: 128-132.
24. Justman QA, Clinton GM. (2002). J Biol Chem 277: 20618-20624.
25. Kari C, Chan TO, Rocha de Quadros M, Rodeck U. (2003). Cancer Res 63: 1-5.
26. Kerr DA, Llado J, Shamblott MJ, Maragakis NJ, Irani DN, Crawford TO et al. (2003). J Neurosci 23: 5131-5140.
27. Klapper LN, Glathe S, Vaisman N, Hynes NE, Andrews GC, Sela M et al. (1999). Proc Natl Acad Sci USA 96: 4995-5000.
28. Kornblum HI, Hussain R, Wiesen J, Miettinen P, Zurcher SD, Chow K et al. (1998). J Neurosci Res 53: 697-717.
29. Kornblum HI, Zurcher SD, Werb Z, Derynck R, Seroogy KB. (1999). Eur J Neurosci 11: 3236-3246.
30. Krueger BK, Burne JF, Raff MC. (1995). J Neurosci 15: 3366-3374.
31. Lee DC, Fenton SE, Berkowitz EA, Hissong MA. (1995). Pharmacol Rev 47: 51-85.
32. Lemke G. (2001). Annu Rev Neurosci 24: 87-105.
33. Leutz A, Schachner M. (1981). Cell Tissue Res 220: 393-404.
34. Levison SW, Jiang FJ, Stoltzfus OK, Ducceschi MH. (2000). Glia 32: 328-337.
35. Malumbres M, Pellicer A. (1998). Front Biosci 3: d887-d912.
36. Matsui Y, Halter SA, Holt JT, Hogan BL, Coffey RJ. (1990). Cell 61: 1147-1155.
37. Moghal N, Sternberg PW. (1999). Curr Opin Cell Biol 11: 190-196.
38. Morrison RS, Kornblum HI, Leslie FM, Bradshaw RA. (1987). Science 238: 72-75.
39. Peschard P, Park M. (2003). Cancer Cell 3: 519-523.
40. Pinkas-Kramarski R, Eilam R, Alroy I, Levkowitz G, Lonai P, Yarden Y. (1997). Oncogene 15: 2803-2815.
41. Prenzel N, Fischer OM, Streit S, Hart S, Ullrich A. (2001). Endocr Relat Cancer 8: 11-31.
42. Prevot V, Lomniczi A, Corfas G, Ojeda SR. (2005). Endocrinology 146: 1465-1472.
43. Prevot V, Rio C, Cho GJ, Lomniczi A, Heger S, Neville CM et al. (2003). J Neurosci 23: 230-239.
44. Rabchevsky AG, Weinitz JM, Coulpier M, Fages C, Tinel M, Junier MP. (1998). J Neurosci 18: 10541-10552.
45. Riese II DJ, Stern DF. (1998). BioEssays 20: 41-48.
46. Rodriguez D, Gauthier F, Bertini E, Bugiani M, Brenner M, N'guyen S et al. (2001). Am J Hum Genet 69: 1134-1140.
47. Ruegg UT, Burgess GM. (1989). Trends Pharmacol Sci 10: 218-220.
48. Saas P, Walker PR, Quiquerez AL, Chalmers DE, Arrighi JF, Lienard A et al. (2002). NeuroReport 13: 1921-1924.
49. Schlessinger J. (2004). Science 306: 1506-1507.
50. Schreiner B, Baur DM, Fingerle AA, Zechner U, Greten FR, Adler G et al. (2003a). Genes Chromosomes Cancer 38: 240-248.
51. Schreiner B, Greten FR, Baur DM, Fingerle AA, Zechner U, Bohm C et al. (2003b). Oncogene 22: 6802-6809.
52. Sibilia M, Steinbach JP, Stingl L, Aguzzi A, Wagner EF. (1998). EMBO J 17: 719-731.
53. Soriano E, Del Rio JA, Auladell C. (1993). J Histochem Cytochem 41: 819-827.
54. Sweeney C, Carraway III KL. (2004). Br J Cancer 90: 289-293.
55. Takuma K, Baba A, Matsuda T. (2004). Prog Neurobiol 72: 111-127.
56. Tang P, Steck PA, Yung WK. (1997). J Neurooncol 35: 303-314.
57. Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA. (1995). Exp Neurol 133: 265-272.
58. Thompson KA, McArthur JC, Wesselingh SL. (2001). Ann Neurol 49: 745-752.
59. Tokita Y, Keino H, Matsui F, Aono S, Ishiguro H, Higashiyama S et al. (2001). J Neurosci 21: 1257-1264.
60. Waterman H, Sabanai I, Geiger B, Yarden Y. (1998). J Biol Chem 273: 13819-13827.
61. Wechsler-Reya R, Scott MP. (2001). Annu Rev Neurosci 24: 385-428.
62. Weickert CS, Blum M. (1995). Dev Brain Res 86: 203-216.
63. Wiley HS. (2003). Exp Cell Res 284: 78-88.
64. Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM. (2000). Oncogene 19: 3999-4010.
65. Xian CJ, Zhou XF. (1999). Mol Neurobiol 20: 157-183.
66. Yaish P, Gazit A, Gilon C, Levitzki A. (1988). Science 242: 933-935.
67. Yarden Y, Sliwkowski MX. (2001). Nat Rev Mol Cell Biol 2: 127-137.
68. Yokoyama M, Black IB, Dreyfus CF. (1993). Exp Neurol 124: 377-380.
69. Zelenaia O, Schlag BD, Gochenauer GE, Ganel R, Song W, Beesley JS et al. (2000). Mol Pharmacol 57: 667-678.